Managed Care
Disease
Management

Reimbursement Considerations In the Treatment of Hypercholesterolemia: Economics and Implications for Medical Groups

Reimbursement Considerations In the Treatment of Hypercholesterolemia: Economics and Implications for Medical Groups

The objective of this roundtable discussion is to review the impact of hypercholesterolemia on cardiovascular risk and public health. In addition, participants explore the clinical and pharmacoeconomic profiles of statins and consider their implications for medical group contracts with HMOs. Among the issues discussed:

  • Overview of therapy and dietary factors
  • Risk-factor management
  • Compliance issues
  • HEDIS guidelines
  • Pharmacoeconomic analysis of therapy
  • Utilization drivers
  • Selecting a therapy

Meetings

Medical Devices Summit Boston, MA February 19–20, 2015
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement Philadelphia, PA March 9–10, 2015
Value-Added Solutions for Enhanced Customer Experience Philadelphia, PA March 9, 2015